why choose us

First received: July 18, 2022

Clinical Trial: Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Gestational Diabetes

Study Type: INTERVENTIONAL


Official Title: Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Brief Summary: This study is being done to study how exenatide, an FDA-approved drug that lowers blood sugar in non-pregnant patients with type II diabetes, works in pregnant women.To do this, the investigators will study the drug's pharmacokinetics (what the body does to the drug; specifically, how quickly your body breaks down and excretes exenatide) and pharmacodynamics (what the drug does to the body; specifically, how effectively exenatide helps the participants' pancreas secrete insulin and how well it controls…

Read more